2 studies found for:    GDC-0994
Show Display Options
Rank Status Study
1 Active, not recruiting A Dose-Escalation Study of GDC-0994 in Patients With Locally Advanced or Metastatic Solid Tumors
Condition: Solid Tumor
Intervention: Drug: GDC-0994
2 Active, not recruiting A Study of the Safety, Tolerability, and Effects of Cobimetinib and GDC-0994 in Patients With Locally Advanced or Metastatic Solid Tumors
Condition: Non-Small Cell Lung Cancer, Metastatic Colorectal Cancer, Metastatic Non Small Cell Lung Cancer, Metastatic Cancers, Melanoma
Interventions: Drug: Cobimetinib;   Drug: GD0-994

Study has passed its completion date and status has not been verified in more than two years.